verified SJR 1,127 · Q1 • database Scopus / SJR & Web of Science indexed

Switzerland

workspace_premium Q1 — Pharmacology lock Subscription Unclaimed

Drug Safety

Drug Safety is a journal indexed in SJR in Pharmacology and Toxicology with an H index of 146. It has a price of 3290 €. It has an SJR impact factor of 1,127 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 1,127.

Drug Safety focuses its scope in these topics and keywords: drug, adverse, safety, surveillance, events, reactions, pharmacovigilance, social, medicines, media, ...

ISSN: 0114-5916

Category: Pharmacology

Indexation: verifiedScopus / SJR verifiedWeb of Science

Unclaimed profile — some fields may be incomplete.

open_in_new Portal NPD menu_book Guidelines NPD

schedule Datos CoP · solo campos en BD

SJR Impact Factor trending_up

1,127 Q1

H-index 146

Tasa de Aceptación pie_chart

22% Selectiva

Fuente Acceptance_Rate

Tiempo a publicación hourglass_top

NPD

Campo Sin dato

Coste de Publicación (APC) payments

3.290 € Subscription

Ruta Non-OA 0 €

Metrics

Campos Scimago / CoP — sin series inventadas

Scopus / SJR Web of Science

SJR Impact

1,127

H-index

146

Docs (year)

119

Docs 3y

338

Total refs

5329

Cites 3y

1223

Citable 3y

297

Cites/Doc 2y

3.65

Ref/Doc

44.78

Immediate OA

3290 €

Embargoed OA

NPD

Non OA / Submission

0 €

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims

rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID * * Only to validate authenticity — identity is not shown publicly.

Best articles by citations

Adverse Effects of Drugs Used in the Management of Constipation and Diarrhoea

WHO Strategy for Collecting Safety Data in Public Health Programmes: Complementing Spontaneous Reporting Systems

Benefits and Risks of Pharmacotherapy for Narcolepsy

Authors' Reply to Harpaz et al. Comment on: "Zoo or Savannah? Choice of Training Ground for Evidence-Based Pharmacovigilance"

Authors' Reply to Ahmad SR: "Adverse Drug Reaction Reporting by Patients: An Overview of Fifty Countries"

Author's Reply to Carracedo-Martinez E Comment on: "Prescribing of Rosiglitazone and Pioglitazone Following Safety Signals: Analysis of Trends in Dispensing Patterns in The Netherlands from 1998 to 2008"

Association Between Statin Use and Bell's Palsy: A Population-Based Study

Aristolochic Acid Nephropathy: Epidemiology, Clinical Presentation, and Treatment

Antiretroviral Therapy in Pregnancy

An Integrated Analysis of the Safety of Tofacitinib in Psoriatic Arthritis across Phase III and Long-Term Extension Studies with Comparison to Real-World Observational Data

Allopurinol Hypersensitivity: A Systematic Review of All Published Cases, 1950-2012

African Heat

SHOW MORE ARTICLES

Adverse Reactions Induced by NSAIDs and Antibacterials

A Comparison of the Empirical Performance of Methods for a Risk Identification System

Adverse Drug Reactions in the Paediatric Population in Denmark

Adverse Drug Reactions in Patients with Phaeochromocytoma

Adverse Drug Reaction Reporting in the UK

Advances in the Pharmacological Treatment of Gastro-Oesophageal Cancer

A Risk-Benefit Assessment of Tacrine in the Treatment of Alzheimer??s Disease

A Risk-Benefit Assessment of Levofloxacin in Respiratory, Skin and Skin Structure, and Urinary Tract Infections

A Risk-Benefit Assessment of Intra-Articular Corticosteroids in Rheumatic Disorders

A Risk-Benefit Assessment of Corticosteroids in the Management of Croup

A Risk-Benefit Assessment of Anthracycline Antibiotics in Antineoplastic Therapy

A Retrospective Evaluation of a Data Mining Approach to Aid Finding New Adverse Drug Reaction Signals in the WHO International Database

FAQS

In Country of Papers you can find SJR impact factor and other metrics to help you decide on a Journal.